Hercules Capital, Inc.
corporate_fare Company Profile
Hercules Capital, Inc. (NYSE:HTGC) is a publicly traded company in the Finance sector. Wiseek has independently scored 21 items for HTGC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-29, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for HTGC spans 8-K, 10-Q, 497AD, FWP.
Recent high-impact activity:
- Hercules Capital Provides $185M Growth Facility to NorthStar Medical
- Hercules Capital Posts Record Q2 NII of $0.50/Share, Declares $0.47 Distribution, and Reports $2.74B in First-Half Commitments
- Hercules Capital Q2 2026: Record NII of $0.50/Share, $0.9B in New Commitments, and $325M Debt Issuance
- Hercules Capital Upsizes Note Offering to $325M at 6.300%
- Hercules Capital Locks In $300M 5-Year Senior Unsecured Notes at T+250bps
Financial Snapshot
Short Interest & Short Volume
7.33 days to coverFINRA reported short interest of 9,402,604 shares in HTGC as of the September 15, 2026 settlement, a 8.4% increase from the prior period — about 7.3 days to cover at its recent average daily volume. On October 2, 2026, 52.0% of HTGC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for HTGC, detected from its recent SEC filings · based on capital-structure filings through 2026-07-21.
$325M Note Offering Priced · Upsized from Earlier $300M Deal
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →